Uncategorized
Pfizer Shares Gain Amid Reports of Deal with the US Government
Pfizer stock climbed over 3% on news of an impending drug-pricing deal with the Trump administration.
Total Stories
25
News
pharma stocks
Section
pharma stocks
Market Analysis
Why Did Eli Lilly (LLY) Shares Surge Today? Key Factors
Eli Lilly shares surged over 4.5% on analyst upgrades, acquisition rumors involving Ventyx Biosciences, and a new $1.3 billion research partnership.
Market Analysis
Why Did Rapport Therapeutics, Inc Shares Skyrocket in Premarket?
Rapport Therapeutics shares surged in premarket trading after announcing positive Phase 2a trial results for RAP-219, showing 77.8% reduction in clinical seizures.
Market Analysis
Novo Nordisk: Is the Ozempic Hype Train Finally Slowing Down?
Ozempic-famed Novo Nordisk took over a $70 billion wipeout off its market value this week. Is this the beginning of a trend, or a great opportunity?
Market Analysis
Why did Novo Nordisk’s Stock Crash Over 20% in Premarket Trading Today?
Novo Nordisk stock crashed over 20% in premarket trading after the company cut its 2025 forecast for the second time.
Market Analysis
Why is CELC Skyrocketing in Premarket Trading Today?
Celcuity's stock surged over 112% in premarket trading following positive Phase 3 trial results for its breast cancer treatment, marking a potential breakthrough in targeted cancer…
Market Analysis
Why did XAGE Stock Surge in Today’s Premarket Trading?
XAGE stock surged over 134% in premarket trading following the announcement of an all-stock merger with THPlasma.
Market Analysis
Why Did INKT Stock Skyrocket in Today’s Premarket Trading?
MiNK Therapeutics stock surged 213% in premarket trading following the publication of a landmark case study showing complete cancer remission in a patient treated with their…
Market Analysis
Moderna’s Shares Gain in Premarket as New Flu Shot Shows Promising Results
Moderna's experimental flu vaccine demonstrated superior efficacy compared to standard flu vaccines in late-stage trials.
Market Analysis
Why Did HIMS Shares Crash Today? Novo Nordisk Terminates Deal Over “Deceptive” Practices
Novo Nordisk ended its month-old partnership with Hims & Hers Health over illegal drug compounding practices.
Market Analysis
Why did Aptevo Therapeutics Shares Skyrocket in Premarket Trading Today?
Aptevo Therapeutics stock soared 123% in premarket trading following promising Phase 1b/2 trial results.
Market Analysis
BioNTech Seals $1.25B CureVac Deal to Accelerate Cancer Treatment Development
BioNTech's $1.25 billion acquisition of CureVac creates a "German biotech champion" focused on mRNA-based cancer treatments, with CureVac shares surging 38% on the announcement.
Market Analysis
Why Did Lyra Therapeutics’ Stock Rocket Past 440% in Premarket Today
Lyra Therapeutics stock surged in premarket trading after announcing positive Phase 3 trial results for a key treatment.